Infection and Immunity: Making 21st Century Vaccines Work & Early Career Researchers’ event
Please circulate to others who may be interested in attending.
The Infection and Immunity Theme recently held a number of small, in-depth group discussions to identify areas where a critical mass of investigators can co-operate synergistically. Four strands emerged around which resources and expertise could coalesce: Antimicrobial resistance; Vaccinology and the microbiome; Biological complexity; and Checkpoint Inhibitors in autoimmunity, cancer and immune-senescence.
A number of RCUK calls in the area of vaccines and vaccinology (a £5M Medical Research Council GCRF call in Networks for Vaccine R&D a BBSRC call across a broad remit that extends to social and community medicine) and a Wellcome Trust statement specifying that vaccination is now one of their priority areas for research funding convinced the Theme that the third strand, Vaccinology and the microbiome, would be the appropriate area to focus on.
This symposium will have three Sessions with the followng speakers plus a poster presentation session;
Session 1 Chair Andrew Davidson
PROF LINDA WOOLDRIDGE (Veterinary Sciences) Technology to decipher T-cell antigen specificity and identify novel antigenic targets
DR EMILY PORTER (Veterinary Sciences ) Design and analysis of vaccine-challenge experiments with multiple outcomes: swine influenza
DR YOHEI YAMAUCHI (Cellular and Molecular Medicine)
Session 2 Chair Linda Wooldridge
PROF ADAM FINN (Clinical Sciences, Cellular and Molecular medicine) Rabies vaccine may do more than prevent rabies - a hypothesis
DR FABIO PARMEGGIANI (Chemistry) Designing modular protein architectures as biological tools
K E Y N O T E : D R BRYAN CHARLESTON, PIRBRIGHT INSTITUTE Foot-and-mouth disease vaccine development using structural vaccinology
Lunch will be provided with Poster presentations from 1 - 2pm.
Session 3 - Early Career Researchers, Chair Adam Finn
SAM ABBOTT (SSCM) Beneficial effects of Bacillus Calmette–Guérin vaccination in outcomes for patients with active Tuberculosis: observational study using the Enhanced Tuberculosis surveillance system 2000-2014
CLIO ANDREAE (Cellular and Molecular Medicine) Use of bioinformatic analysis to inform Neisseria meningitis vaccine candidate design on the trimeric autotransporter Msf
GEMMA LASSETER (SSCM) Population preferences for prioritising vaccination programmes against childhood diseases: developing a discrete choice experiment
CAROLINE MORRIS (Chemistry) Exploring the potential of self-assembling peptide cages as vaccine delivery platforms
ADAM ZIENKIEWICZ ( Veterinary Sciences, Engineering) Individual-based modelling study of antimicrobial resistant Neisseria gonorrhoeae transmission, diagnosis and treatment in men who have sex with men
GEORGINA TAYLOR ( SSCM ) Investigating the relationship between vaccine status and the presence of respiratory microbes in children attending primary care
This will bring key groups together across veterinary medicine, clinical medicine and clinical science.
Bristol has strength in the “One Health” concept, with the ability to bring together experts across human and veterinary medicine and combines expertise in mucosal immunology, molecular microbiology, clinical vaccine trials and epidemiological modelling to make research into population-wide vaccine effects on transmission of infections a strength area.